The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Butyrate-producing commensal bacteria mediates the efficacy of herbal medicine JCM-16021 on abdominal pain in diarrhea-predominant irritable bowel syndrome: a randomized clinical trial
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Three Chinese herbal preparations that have been studied in clinical trials in IBS patients and demonstrated beneficial effects are the following:”
From Plant-Derived Treatments for IBS: Clinical Outcomes, Mechanistic Insights, and Their Position in International Guidelines (2026) · cites this paper as [54]
In the citing paper
“Furthermore, by modulating short-chain fatty acid (SCFA) producers, JCM-16021 relieves abdominal pain in rats, as demonstrated through a fecal microbiota transplantation (FMT) study [54].”
From Plant-Derived Treatments for IBS: Clinical Outcomes, Mechanistic Insights, and Their Position in International Guidelines (2026) · cites this paper as [54]
In the citing paper
“These randomized clinical trials demonstrated that JCM-16021 alleviates abdominal pain in patients with IBS-D [52,54].”
From Plant-Derived Treatments for IBS: Clinical Outcomes, Mechanistic Insights, and Their Position in International Guidelines (2026) · cites this paper as [54]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research
Percie du Sert, N., Hurst, V., Ahluwalia, A., Alam, S., Avey, M. T., Baker, M., Browne, W. J., Clark, A., Cuthill, I. C., Dirnagl, U., et al. (2020) · PLOS Biology · doi:10.1371/journal.pbio.3000410 · Cited by 5,939
Beghini, F., McIver, L. J., Blanco-Míguez, A., Dubois, L., Asnicar, F., Maharjan, S., Mailyan, A., Manghi, P., Scholz, M., Thomas, A. M., et al. (2021) · eLife · doi:10.7554/elife.65088 · Cited by 2,303
Kim, M. H., Kang, S. G., Park, J. H., Yanagisawa, M., & Kim, C. H. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.04.056 · Cited by 1,127
Eluxadoline for Irritable Bowel Syndrome with Diarrhea
Lembo, A. J., Lacy, B. E., Zuckerman, M. J., Schey, R., Dove, L. S., Andrae, D. A., Davenport, J. M., McIntyre, G., Lopez, R., Turner, L., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1505180 · Cited by 334
Ma, X., Zhou, Z., Zhang, X., Fan, M., Hong, Y., Feng, Y., Dong, Q., Diao, H., & Wang, G. (2020) · Cell Biology and Toxicology · doi:10.1007/s10565-020-09518-4 · Cited by 131
Self-citation
Research works printed but not linked: 29
- Bayrer, 2023, Gut enterochromaffin cells drive visceral pain and anxiety, Nature, 616, 137, 10.1038/s41586-023-05829-8 · DOI
- Black, 2020, Efficacy of eluxadoline in irritable bowel syndrome with diarrhea, Am. J. Gastroenterol., 115, 483, 10.14309/ajg.0000000000000518 · DOI
- Bonomo, 2020, Fecal transplantation and butyrate improve neuropathic pain, modify immune cell profile, and gene expression in the PNS of obese mice, Proc. Natl. Acad. Sci. u S. a, 117, 26482, 10.1073/pnas.2006065117 · DOI
- Cheng, 2017, CONSORT extension for Chinese herbal medicine formulas 2017: recommendations, explanation, and elaboration, Ann. Intern. Med., 167, 112, 10.7326/M16-2977 · DOI · Paper page
- Chey, 2015, Irritable bowel syndrome: a clinical review, JAMa, 313, 949, 10.1001/jama.2015.0954 · DOI · Paper page
- Enck, 2020, Placebo responses and Placebo effects in functional gastrointestinal disorders, Front. Psychiatry, 11, 797, 10.3389/fpsyt.2020.00797 · DOI
- Fusco, 2023, Short-chain fatty-acid-producing bacteria: key components of the Human gut microbiota, Nutrients., 15, 10.3390/nu15092211 · DOI · Paper page
- Gou, 2023, Traditional medicine Pien Tze Huang suppresses colorectal tumorigenesis through restoring gut microbiota and metabolites, Gastroenterology, 165, 1404, 10.1053/j.gastro.2023.08.052 · DOI
- Hamer, 2012, Functional analysis of colonic bacterial metabolism: relevant to health?, Am. J. Physiol. Gastrointest. Liver. Physiol., 302, G1, 10.1152/ajpgi.00048.2011 · DOI
- Jiang, 2025, Roseburia intestinalis-derived butyrate alleviates neuropathic pain, Cell Host. Microbe, 33, 104, 10.1016/j.chom.2024.11.013 · DOI
- Lau, 2012, ATF2 - at the crossroad of nuclear and cytosolic functions, J. Cell Sci., 125, 2815
- Lembo, 2022, AGA clinical practice guideline on the pharmacological management of irritable bowel syndrome with diarrhea, Gastroenterology, 163, 137, 10.1053/j.gastro.2022.04.017 · DOI · Paper page
- Li, 2021, Microbiota metabolite butyrate constrains neutrophil functions and ameliorates mucosal inflammation in inflammatory bowel disease, Gut. Microbes., 13, 10.1080/19490976.2021.1968257 · DOI
- Li, 2011, Essential roles of enteric neuronal serotonin in gastrointestinal motility and the development/survival of enteric dopaminergic neurons, J. Neurosci., 31, 8998, 10.1523/JNEUROSCI.6684-10.2011 · DOI · Paper page
- Nee, 2021, Review article: current and future treatment approaches for IBS with diarrhoea (IBS-D) and IBS mixed pattern (IBS-M), Aliment. Pharmacol. Ther., 54, S63
- Nozu, 2019, Butyrate inhibits visceral allodynia and colonic hyperpermeability in rat models of irritable bowel syndrome, Sci. Rep., 9, 10.1038/s41598-019-56132-4 · DOI
- Paine, 2021, Review article: current and future treatment approaches for pain in IBS, Aliment. Pharmacol. Ther., 54, S75
- Perna, 2021, Effect of resolvins on sensitisation of TRPV1 and visceral hypersensitivity in IBS, Gut, 70, 1275, 10.1136/gutjnl-2020-321530 · DOI
- Qin, 2012, JCM-16021, a Chinese herbal formula, attenuated visceral hyperalgesia in TNBS-induced postinflammatory irritable bowel syndrome through reducing colonic EC cell hyperplasia and serotonin availability in rats, Evid. Based. Complement. Alternat. Med., 2012, 10.1155/2012/239638 · DOI · Paper page
- Quan, 2025, Fecal proteolytic bacteria and staphylococcal superantigens are associated with abdominal pain severity in irritable bowel syndrome, Am. J. Gastroenterol., 120, 603, 10.14309/ajg.0000000000003042 · DOI
- Russo, 2016, Sodium butyrate and its synthetic amide derivative modulate nociceptive behaviors in mice, Pharmacol. Res., 103, 279, 10.1016/j.phrs.2015.11.026 · DOI
- Shi, 2025, Butyrate-producing faecalibacterium prausnitzii suppresses natural killer/T-cell lymphoma by dampening the JAK-STAT pathway, Gut, 74, 557, 10.1136/gutjnl-2024-333530 · DOI
- Smith, 2013, The microbial metabolites, short-chain fatty acids, regulate colonic treg cell homeostasis, Science (1979), 341, 569
- Stefka, 2014, Commensal bacteria protect against food allergen sensitization, Proc. Natl. Acad. Sci. u S. a, 111, 13145, 10.1073/pnas.1412008111 · DOI
- Trivedi, 2022, A concise review of liquid chromatography-mass spectrometry-based quantification methods for short chain fatty acids as endogenous biomarkers, Int. J. Mol. Sci., 23, 10.3390/ijms232113486 · DOI
- Ventura, 2009, Microbial diversity in the human intestine and novel insights from metagenomics, Front. Biosci. (Landmark. Ed), 14, 3214, 10.2741/3445 · DOI
- Wang, 2020, Microbiota-derived butyrate dynamically regulates intestinal homeostasis through regulation of actin-associated protein synaptopodin, Proc. Natl. Acad. Sci. u S. a, 117, 11648, 10.1073/pnas.1917597117 · DOI · Paper page
- Zhai, 2023, Ruminococcus gnavus plays a pathogenic role in diarrhea-predominant irritable bowel syndrome by increasing serotonin biosynthesis, Cell Host. Microbe, 31, 10.1016/j.chom.2022.11.006 · DOI
- Zheng, 2021, Efficacy and safety of Chinese medicine JCM-16021 for diarrhea-predominant irritable bowel syndrome: study protocol for a multi-center, randomized, double-blind, placebo controlled clinical trial, Chin. Med., 16, 117, 10.1186/s13020-021-00530-2 · DOI · Paper page
Cited by
Pastras, P., Aggeletopoulou, I., Bali, M., & Triantos, C. (2026) · Nutrients · doi:10.3390/nu18020183 · Cited by 1
Metadata
- Authors
- Zhai, L., Zheng, Y., Lo, C. W., Xu, S., Jiang, X., Liu, Q., Ching, J. Y., Ning, Z., Bao, G., Yang, W., Zhang, Q., Cheng, C. W., Lam, W. C., Chan, K. L., Zhang, X., Lam, P. Y., Wu, X. Y., Zhong, L. L. D., Cao, P. H., Koh, M., Cheong, P. K., Lin, Z., Lin, C., Zhao, L., Wong, X. H. L., Wu, J. C., & Bian, Z.
- Venue
- Phytomedicine
- Publisher
- Elsevier BV
- Published
- 2025-09
- Volume
- 145
- Pages
- 157040
- ISSN
- 0944-7113
- Cited by
- 9
- References
- 5
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- creativecommons.org/licenses/by-nc/4.0/ (vor)
- Funders
- National Natural Science Foundation of China (82370553, 81973538)
- Innovation and Technology Commission
- General Research Fund of Shanghai Normal University (12100323)
- Health and Medical Research Fund (17182661)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.